Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma

Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Investig Med High Impact Case Rep
Hlavní autoři: Kichloo, Asim, Albosta, Michael S., McMahon, Shane, Movsesian, Kimberly, Wani, Farah, Jamal, Shakeel M., Aljadah, Michael, Singh, Jagmeet
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448133/
https://ncbi.nlm.nih.gov/pubmed/32830561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709620951339
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky